USA: The RECOVER Initiative - Long Covid research

Maybe i should reply on bluesky but LDN and Baricitinib are already being thoroughly trialed (although I guess LDN is being trialed in ME). GLP1 is an interesting idea I suppose, not sure what the rationale is. As for SGB, I am really skeptical, but I suppose it's better to have a trial than not so we have a clear result.

Deeply disappointing lineup imo.
 
V.R.T. said:
Deeply disappointing lineup imo.
Click to expand...
Agreed. And in anycase I’d rather have it go towards solid biomed research than another treatment trial with long covid (which is such a vague clinical construct very unlikely a treatment works for most cases). If they’re insisting on treatment trial much rather they’d do a well defined subset.

Pinging @Dakota15 given they were interested in knowing people’s opinions.
 
You must log in or register to reply here.
Back
Top Bottom